Analysis of Cost Effectiveness of KRAS / BRAF Mutation Tests in Metastatic Colon Cancer Treatment
Sülkü S. N., Aydin Son Y., Işil Ülman F. Y.
AB Destekli Diğer Projeler, 2021 - 2021
- Proje Türü: AB Destekli Diğer Projeler
- Başlama Tarihi: Ocak 2021
- Bitiş Tarihi: Mayıs 2021
Proje Özeti
ERA PerMed JTC2021
Analysis of Cost Effectiveness of KRAS / BRAF Mutation Tests in Metastatic Colon Cancer Treatment
Key Words:
Biomarker, KRAS/BRAF, Colorectal Cancer, Cost-Effectiveness, Machine Learning, Health Econometrics, Artificial Intelligence